Zacks
Here's Why You Should Hold DexCom Stock in Your Portfolio for Now
📈
AI Sentiment
Highly Positive
8/10
- Home
- CAH
as of 03-17-2026 11:50am EST
$215.26
$2.33
-1.07%
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
| Founded: | 1979 | Country: | United States |
| Employees: | N/A | City: | DUBLIN |
| Market Cap: | 51.2B | IPO Year: | 1994 |
| Target Price: | $230.45 | AVG Volume (30 days): | 1.3M |
| Analyst Decision: | Buy | Number of Analysts: | 11 |
| Dividend Yield: | Dividend Payout Frequency: | quarterly | |
| EPS: | 1.88 | EPS Growth: | 86.96 |
| 52 Week Low/High: | $120.72 - $233.60 | Next Earning Date: | N/A |
| Revenue: | $222,578,000,000 | Revenue Growth: | -1.87% |
| Revenue Growth (this year): | 17.38% | Revenue Growth (next year): | 9.00% |
| P/E Ratio: | 115.39 | Index: | |
| Free Cash Flow: | 1.9B | FCF Growth: | N/A |
AI-Powered CAH Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated 16 hours ago
AI Recommendation
hold
Model Accuracy: 72.73%
72.73%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Cardinal Health Inc. (CAH)
Greene Michelle D.
Sell
Chief Information Officer
CAH Feb 27, 2026
Avg Cost/Share
$228.51
Shares
2,746
Total Value
$627,386.62
Owned After
14,876
Alt Aaron E
Sell
Chief Financial Officer
CAH Feb 18, 2026
Avg Cost/Share
$225.50
Shares
2,328
Total Value
$524,964.00
Owned After
26,408
SEC Form 4
Hall Patricia Hemingway
Sell
Director
CAH Feb 6, 2026
Avg Cost/Share
$229.72
Shares
4,000
Total Value
$918,880.00
Owned After
28,264
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Greene Michelle D. | CAH | Chief Information Officer | Feb 27, 2026 | Sell | $228.51 | 2,746 | $627,386.62 | 14,876 | |
| Alt Aaron E | CAH | Chief Financial Officer | Feb 18, 2026 | Sell | $225.50 | 2,328 | $524,964.00 | 26,408 | |
| Hall Patricia Hemingway | CAH | Director | Feb 6, 2026 | Sell | $229.72 | 4,000 | $918,880.00 | 28,264 |
Earnings Transcripts
SEC 8-K filings with transcript text
2025 Q4 Q4 2025 Earnings
8-K BUY Feb 5, 2026 · 100% conf.
2025
Q4
Q4 2025 Earnings
8-K BUYFeb 5, 2026 · 100% conf.
AI Prediction BUY
1D
+0.45%
$228.21
Act: -0.38%
5D
+2.75%
$233.43
Act: -5.33%
20D
+5.62%
$239.94
Act: -3.90%
Price: $227.18 Prob +5D: 100% AUC: 1.000
0000721371-26-000004
cah-202602050000721371false00007213712026-02-052026-02-05
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 5, 2026
Cardinal Health, Inc. (Exact name of registrant as specified in its charter)
Ohio1-1137331-0958666 (State or other jurisdiction of incorporation)(Commission File Number)
(IRS Employer Identification No.)
7000 Cardinal Place, Dublin, Ohio 43017 (614) 757-5000 (Registrant’s telephone number, including area code) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act: Title of each classTrading Symbol(s)Name of each exchange on which registered Common shares (without par value)CAHNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. p
Item 2.02: Results of Operations and Financial Condition On February 5, 2026, Cardinal Health, Inc. (the "Company") issued a news release announcing its results for the quarter ended December 31, 2025. A copy of the news release is included as Exhibit 99.1 to this report.
Item 7.01: Regulation FD Disclosure During a webcast scheduled to be held at 8:30 a.m. Eastern time on February 5, 2026, the Company's Chief Executive Officer and Chief Financial Officer will discuss the Company's results for the quarter ended December 31, 2025 and outlook for the fiscal year ending June 30, 2026. The slide presentation for the webcast will be available on the Investors page at ir.cardinalhealth.com. An audio replay of the webcast also will be available on the Investors page at ir.cardinalhealth.com.
Item 9.01: Financial Statements and Exhibits (d) Exhibits
Exhibit NumberExhibit Description 99.1News release issued by the Company on February 5, 2026 announcing second-quarter results.
2
Signatures Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Cardinal Health, Inc. (Registrant)
Date:February 5, 2026By:/s/ AARON E. ALT Aaron E. Alt Chief Financial Officer
3
2025 Q3 Q3 2025 Earnings
8-K Oct 30, 2025
2025
Q3
Q3 2025 Earnings
8-KOct 30, 2025
0000721371-25-000128
cah-202510300000721371false00007213712025-10-302025-10-30
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 30, 2025
Cardinal Health, Inc. (Exact name of registrant as specified in its charter)
Ohio1-1137331-0958666 (State or other jurisdiction of incorporation)(Commission File Number)
(IRS Employer Identification No.)
7000 Cardinal Place, Dublin, Ohio 43017 (614) 757-5000 (Registrant’s telephone number, including area code) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act: Title of each classTrading Symbol(s)Name of each exchange on which registered Common shares (without par value)CAHNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. p
Item 2.02: Results of Operations and Financial Condition On October 30, 2025, Cardinal Health, Inc. (the "Company") issued a news release announcing its results for the quarter ended September 30, 2025. A copy of the news release is included as Exhibit 99.1 to this report.
Item 7.01: Regulation FD Disclosure During a webcast scheduled to be held at 8:30 a.m. Eastern time on October 30, 2025, the Company's Chief Executive Officer and Chief Financial Officer will discuss the Company's results for the quarter ended September 30, 2025 and outlook for the fiscal year ending June 30, 2026. The slide presentation for the webcast will be available on the Investors page at ir.cardinalhealth.com. An audio replay of the webcast also will be available on the Investors page at ir.cardinalhealth.com.
Item 9.01: Financial Statements and Exhibits (d) Exhibits
Exhibit NumberExhibit Description 99.1News release issued by the Company on October 30, 2025 announcing first-quarter results.
2
Signatures Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Cardinal Health, Inc. (Registrant)
Date:October 30, 2025By:/s/ AARON E. ALT Aaron E. Alt Chief Financial Officer
3
2025 Q2 Q2 2025 Earnings
8-K Aug 12, 2025
2025
Q2
Q2 2025 Earnings
8-KAug 12, 2025
0000721371-25-000075
cah-202508120000721371false00007213712025-08-122025-08-12
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 12, 2025
Cardinal Health, Inc. (Exact name of registrant as specified in its charter)
Ohio1-1137331-0958666 (State or other jurisdiction of incorporation)(Commission File Number)
(IRS Employer Identification No.)
7000 Cardinal Place, Dublin, Ohio 43017 (614) 757-5000 (Registrant’s telephone number, including area code) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act: Title of each classTrading Symbol(s)Name of each exchange on which registered Common shares (without par value)CAHNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. p
Item 2.02: Results of Operations and Financial Condition On August 12, 2025, Cardinal Health, Inc. (the "Company") issued a news release announcing its results for the quarter and fiscal year ended June 30, 2025. A copy of the news release is included as Exhibit 99.1 to this report.
Item 7.01: Regulation FD Disclosure During a webcast scheduled to be held at 8:30 a.m. Eastern time on August 12, 2025, the Company's Chief Executive Officer and Chief Financial Officer will discuss the Company's results for the quarter and fiscal year ended June 30, 2025 and outlook for the fiscal year ending June 30, 2026. The slide presentation for the webcast will be available on the Investors page at ir.cardinalhealth.com. An audio replay of the webcast also will be available on the Investors page at ir.cardinalhealth.com. The Company also issued a news release on August 12, 2025, announcing that its multi-specialty management services organization, The Specialty Alliance, has entered into a definitive agreement to acquire Solaris Health. This news release is being furnished as Exhibit 99.2 to this Form 8-K.
Item 9.01: Financial Statements and Exhibits (d) Exhibits
Exhibit NumberExhibit Description 99.1News release issued by the Company on August 12, 2025 announcing fourth-quarter and year-end results.
99.2News release issued by the Company on August 12, 2025 announcing the entry into an agreement to acquire of Solaris Health
2
Signatures Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Cardinal Health, Inc. (Registrant)
Date:August 12, 2025By:/s/ AARON E. ALT Aaron E. Alt Chief Financial Officer
3
Latest Cardinal Health Inc. News
CAH Breaking Stock News: Dive into CAH Ticker-Specific Updates for Smart Investing
Zacks
NTRA Debuts Zenith Genomics Next-Gen Sequencing Test for Rare Diseases
📈
AI Sentiment
Highly Positive
8/10
Simply Wall St.
Does Raised 2026 Guidance and CAO Exit Reshape the Bull Case For Cardinal Health (CAH)?
📈
AI Sentiment
Highly Positive
8/10
Investor's Business Daily
Defense IPO Leads Five Stocks To Watch As Iran War Pressures Market
📊
AI Sentiment
Positive
6/10
Investor's Business Daily
How Cardinal Health, The IBD Stock Of The Day, Is Navigating The Tricky Macro
📈
AI Sentiment
Highly Positive
8/10
Zacks
Veeva Acquires Ostro to Expand AI-Powered Engagement in Life Sciences
📊
AI Sentiment
Positive
7/10
Zacks
XRAY & Siemens Healthineers Secure FDA Nod for Dental-Dedicated MRI
📊
AI Sentiment
Positive
6/10
Zacks
CAH's Pharma Segment Gains 19% in Q2'26: Is the Growth Sustainable?
📈
AI Sentiment
Highly Positive
9/10
Compare CAH vs Leading Stocks
See how CAH stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "CAH Cardinal Health Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.